WallStreetZenWallStreetZen

NASDAQ: BLRX
Biolinerx Ltd Earnings & Revenue

BLRX earnings and revenue history

Current Revenue
$11.7M
Current Earnings
-$49.1M
Current Profit Margin
-421.7%

BLRX Return on Equity

Current Company
-325.1%
Current Industry
16.3%
Current Market
28.2%
BLRX's Return on Equity (-325.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BLRX announces earnings.

BLRX Return on Assets

Current Company
-86.5%
Current Industry
2.7%
BLRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BLRX Return on Capital Employed

Current Company
-232.25%
Current Industry
-43.1%
BLRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BLRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BLRX$11.66M-$44.96M-$49.15MN/AN/A
KZR$7.00M-$98.68M-$101.33MN/AN/A
ABIO$0.00-$5.90M-$6.00MN/AN/A
LEXX$386.00k-$5.24M-$5.45M+7.07%N/A
CASI$33.88M-$22.29M-$26.96M+69.23%N/A

Biolinerx Earnings & Revenue FAQ

What were BLRX's earnings last quarter?

On Invalid Date, Biolinerx (NASDAQ: BLRX) reported Q1 2024 earnings per share (EPS) of $0.00, up 100% year over year. Total Biolinerx earnings for the quarter were -$696.00 thousand. In the same quarter last year, Biolinerx's earnings per share (EPS) was -$0.01.

If you're new to stock investing, here's how to buy Biolinerx stock.

What was BLRX's earnings growth in the past year?

As of Q2 2024, Biolinerx's earnings has grown year over year. Biolinerx's earnings in the past year totalled -$49.15 million.

What was BLRX's revenue last quarter?

On Invalid Date, Biolinerx (NASDAQ: BLRX) reported Q1 2024 revenue of $6.86 million up Infinity% year over year. In the same quarter last year, Biolinerx's revenue was $0.00.

What was BLRX's revenue growth in the past year?

As of Q2 2024, Biolinerx's revenue has grown null year over year. Biolinerx's revenue in the past year totalled $11.66 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.